Christopher Ogden, CFO: CytomX Therapeutics CTMX Sell · Filed 25/06/17

Trade details

Type: Insider sale
Amount: $28,551.66
Shares · price: 10,614 sh · $2.69 a share
Held after: 226,271 sh
Stock: CytomX Therapeutics CTMX
Person: Christopher OgdenCFO
Trade date: 25/06/16
Filed: 25/06/17
Days to filing: 1 days

Sold 4.5% of holdings

Share of holding sold: 4.5%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/17~25/07/16

Christopher Ogden's recent trades

Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,953
1,624 sh
$4,953
Filed 06/17
Traded 06/15
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$124.1K
19,323 sh
$124.1K
Filed 03/19
Traded 03/17
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,841
1,641 sh
$4,841
Filed 25/06/17
Traded 25/06/13
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,131
8,551 sh
$5,131
Filed 25/03/20
Traded 25/03/18
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$2,440
1,984 sh
$2,440
Filed 24/08/22
Traded 24/08/20